An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions: in regard to Lawton et al. (Int J Radiat Oncol Biol Phys 2007;69:646-655.)

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):316; author reply 316. doi: 10.1016/j.ijrobp.2008.01.009.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Clinical Trials, Phase III as Topic
  • Combined Modality Therapy / methods
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / immunology*
  • Prostatic Neoplasms / radiotherapy
  • Randomized Controlled Trials as Topic
  • Regeneration / immunology
  • T-Lymphocytes / immunology*
  • Thymus Gland / physiology*

Substances

  • Androgen Antagonists